Dawudi, Y., Benarroch, S., Helfer, H., Smadja, D. M., & Mahé, I. Janus kinase inhibitor treatment for inflammatory diseases: Excess or no excess risk of venous thromboembolism? Elsevier.
Chicago Style (17th ed.) CitationDawudi, Yachar, Samuel Benarroch, Hélène Helfer, David M. Smadja, and Isabelle Mahé. Janus Kinase Inhibitor Treatment for Inflammatory Diseases: Excess or No Excess Risk of Venous Thromboembolism? Elsevier.
MLA (9th ed.) CitationDawudi, Yachar, et al. Janus Kinase Inhibitor Treatment for Inflammatory Diseases: Excess or No Excess Risk of Venous Thromboembolism? Elsevier.
Warning: These citations may not always be 100% accurate.